Of note, the lack of Grx2 in mitochondria led to changes in metabolic phenotype, as evidenced by increased body weight, the accumulation of fat in the liver, and augmented plasma lipid levels, which resulted in fatty liver diseases [36]. Here, GLRX2 is linked to fatty liver disease.